Phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma

Trial Profile

Phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary) ; Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Sponsors Burzynski Research Institute
  • Most Recent Events

    • 14 Apr 2016 Results from this trial published in Child's Nervous System in December 2014, as per Burzynski Research Institute, Inc media release.
    • 16 Apr 2015 Results of subgroup analysis in patients with non-diffuse intrinsic pontine glioma published in Journal of Cancer Therapy, according to a Burzynski Research Institute media release.
    • 16 Apr 2015 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top